ABF:LSEAssociated British Foods plc Analysis
Data as of 2026-03-11 - not real-time
£1,842.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Associated British Foods (ABF.L) is trading at £18.42 (1842 GBp), roughly 6% above its DCF‑derived fair value of £9.62, while sitting below its 20‑day (1927) and 50‑day (1930) SMA, indicating a short‑term bearish bias. The RSI of 34 suggests the stock is approaching oversold conditions, and the MACD histogram remains negative, reinforcing the current downtrend. Support around £18.32 (1832 GBp) appears firm, bolstered by an increasing volume trend, but downside pressure persists given the 30‑day volatility of over 21%. On the fundamentals side, the company delivers a modest PE of 12.97 and a forward PE of 10.17, with a respectable dividend yield of 3.41% and a payout ratio near 45%, supporting dividend sustainability. Revenue has slipped 3.8% YoY, and margins remain thin (gross 8.1%, operating 8.8%), reflecting limited growth momentum. Recent material news of a second tranche of share buy‑backs signals management confidence and could provide upside if execution proceeds smoothly.
Overall, ABF offers a defensive, low‑beta exposure (beta ~0.14) with solid cash generation (free cash flow ~£0.68 bn) and a stable balance sheet, though the lack of top‑line growth and bearish technical signals temper enthusiasm. The dividend’s sustainability, low volatility, and defensive sector positioning make the stock attractive for income‑focused investors, while the current price proximity to support and the buy‑back programme may offer a modest catalyst. However, the negative trend indicators and modest upside potential warrant a cautious stance, especially in the near term.
Overall, ABF offers a defensive, low‑beta exposure (beta ~0.14) with solid cash generation (free cash flow ~£0.68 bn) and a stable balance sheet, though the lack of top‑line growth and bearish technical signals temper enthusiasm. The dividend’s sustainability, low volatility, and defensive sector positioning make the stock attractive for income‑focused investors, while the current price proximity to support and the buy‑back programme may offer a modest catalyst. However, the negative trend indicators and modest upside potential warrant a cautious stance, especially in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support at £18.32
- increasing volume but bearish MACD
- RSI indicating oversold conditions
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- fair valuation relative to earnings multiples
- stable dividend yield of 3.41% with sustainable payout
- ongoing share buy‑back programme supporting price
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- defensive consumer‑staples sector with low beta
- consistent free cash flow generation
- strong dividend sustainability and management confidence via buy‑backs
Key Metrics & Analysis
Financial Health
Revenue Growth-3.80%
Profit Margin5.27%
P/E Ratio13.0
ROE9.30%
ROA5.37%
Debt/Equity32.95
P/B Ratio118.6
Op. Cash Flow£2.2B
Free Cash Flow£677.6M
Technical Analysis
TrendBearish
RSI34.0
Support£1,832.00
Resistance£2,010.00
MA 20£1,927.28
MA 50£1,930.34
MA 200£2,087.76
MACDBearish
VolumeIncreasing
Fear & Greed Index75.7
Valuation
Fair Value£961.73
Target Price£1,953.61
Upside/Downside6.06%
GradeFair
TypeValue
Dividend Yield3.41%
Risk Assessment
Beta0.14
Volatility21.08%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.